Bottom Line Booster

July 1, 2001
Stephen Kirkpatrick

Stephen Kirkpatrick is a manager for PRTM , a global pharmaceutical management consulting firm.

,
Todd Jackson

Todd Jackson is a principal for PRTM , a global pharmaceutical management consulting firm.

,
Robert J. Franco, PhD

Robert J. Franco, PhD,is a director of the Worldwide Life Sciences Practice of management consulting firm PRTM

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-07-01-2001, Volume 0, Issue 0

Given the colossal revenue generated by just one blockbuster drug, it's no surprise that R&D always finds its way to the top of management's agenda. But now more than ever, pharmaceutical companies can't thrive on discovery alone. Price pressure from the public and private sectors drives companies to create savings through operational efficiencies. One of the biggest areas for financial gain"better management of capital assets"is often overlooked.

Related Content:

News